Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy

Giorgio Ciprandi; Attilio Varricchio; Ignazio La Mantia

doi:10.65396/ejra.1825453

Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy

Abstract

OBJECTIVE Nasal topical therapy plays a pivotal role in the management of a wide range of upper airway conditions, including allergic rhinitis, chronic rhinosinusitis, and postoperative care in nasal surgeries. The aim is to report a post hoc analysis on a survey on topical nasal therapy that included an extended list of pharmacological and non-pharmacological products to manage several upper respiratory tract diseases. METHODS This survey involved a questionnaire distributed via a web platform that ensured anonymity. Fellows of ORL Italian societies participated in the survey. The panel of experts who developed the Delphi Consensus drafted the questionnaire. RESULTS One hundred eight ORLs participated in the survey. Most of them were from Southern Italy and islands (57.4%). The most common disease topically treated is chronic rhinosinusitis with nasal polyps (82.4%), followed by allergic rhinitis (78.3%), non-allergic rhinitis (76.7%), chronic rhinosinusitis without nasal polyps (76.5%), chronic adenoiditis (73.4%), and acute rhinosinusitis and adenoiditis (70% and 69.8%, respectively). CONCLUSION This survey demonstrated that a group of Italian ORLs use topical nasal therapy essentially for type 2-mediated and infectious/inflammatory diseases, prefer a pre-dosed nasal spray and irrigation, and prescribe mostly corticosteroids and saline solutions.

Keywords

References

1. Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review. Drug Deliv Transl Res. 2013;3(1):42–62.
2. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CC, Schuller D, Spector SL, Tilles SA; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):1–84.
3. Meltzer EO, et al. Intranasal corticosteroids: pharmacology and new formulations. Allergy Asthma Proc. 2019;40(1):2–12.
4. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;(3):CD006394.
5. Albu S. Use of topical antibiotics in chronic rhinosinusitis without polyps: an update. Am J Rhinol Allergy. 2014;28(2):157–163.
6. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004 Jun;113(6):1122-1128.
7. Kaiser HB. The role of antihistamines in the treatment of asthma. J Allergy Clin Immunol. 2000;105(2):622–626.
8. Costantino HR, et al. Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm. 2007;337(1–2):1–24.

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Authors

Giorgio Ciprandi This is me
Italy

Attilio Varricchio This is me
Italy

Ignazio La Mantia This is me
Italy

Publication Date

August 31, 2025

Submission Date

April 30, 2025

Acceptance Date

June 19, 2025

Published in Issue

Year 2025 Volume: 8 Number: 2

DOI

https://doi.org/10.65396/ejra.1825453

IZ

https://izlik.org/JA75LX48BF

Cite

RIS / Bibtex

APA

Ciprandi, G., Varricchio, A., & La Mantia, I. (2025). Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. European Journal of Rhinology and Allergy, 8(2), 53-55. https://doi.org/10.65396/ejra.1825453

AMA

1.Ciprandi G, Varricchio A, La Mantia I. Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. Eur J Rhinol Allergy. 2025;8(2):53-55. doi:10.65396/ejra.1825453

Chicago

Ciprandi, Giorgio, Attilio Varricchio, and Ignazio La Mantia. 2025. “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”. European Journal of Rhinology and Allergy 8 (2): 53-55. https://doi.org/10.65396/ejra.1825453.

EndNote

Ciprandi G, Varricchio A, La Mantia I (August 1, 2025) Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. European Journal of Rhinology and Allergy 8 2 53–55.

IEEE

[1]G. Ciprandi, A. Varricchio, and I. La Mantia, “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”, Eur J Rhinol Allergy, vol. 8, no. 2, pp. 53–55, Aug. 2025, doi: 10.65396/ejra.1825453.

ISNAD

Ciprandi, Giorgio - Varricchio, Attilio - La Mantia, Ignazio. “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”. European Journal of Rhinology and Allergy 8/2 (August 1, 2025): 53-55. https://doi.org/10.65396/ejra.1825453.

JAMA

1.Ciprandi G, Varricchio A, La Mantia I. Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. Eur J Rhinol Allergy. 2025;8:53–55.

MLA

Ciprandi, Giorgio, et al. “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”. European Journal of Rhinology and Allergy, vol. 8, no. 2, Aug. 2025, pp. 53-55, doi:10.65396/ejra.1825453.

Vancouver

1.Giorgio Ciprandi, Attilio Varricchio, Ignazio La Mantia. Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. Eur J Rhinol Allergy. 2025 Aug. 1;8(2):53-5. doi:10.65396/ejra.1825453